GlobalData

Data analytics and intelligence company whose Pharma Intelligence Center covers drugs, trials, deals, and market forecasts.

GlobalData, established in 1999 and headquartered in London, United Kingdom, is a publicly listed data analytics and consulting company (LSE: DATA) whose Pharma Intelligence Center provides databases and analytics covering drug pipelines, clinical trials, deals, epidemiology, and market forecasts, with AI-assisted search and summarization layered over its curated datasets. It is an intelligence and forecasting resource rather than an operational system. Atlas found no vendor-held security certifications documented on its site.

Headquarters
London, United Kingdom
Founded
1999
Deployment options
cloud
Website
https://www.globaldata.com

Categories

AI Use Cases

  • Market Access & HTA Strategy

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents GlobalData across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial, Medical Affairs

Solution Scope — Documented

Market Access Analytics

Company Viability — Partially documented

Public, Founded 1999

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • How current are the pipeline and trials databases, and how is data curated?
  • Which forecast models cover our therapeutic area and markets?
  • What API or data feed options exist for integrating into our systems?
  • How does licensing scale across teams and geographies?